Sheyanth Mohanakumar1,2, Niklas Telinius1,2, Benjamin Kelly1,2, Henrik Lauridsen3, Donna Boedtkjer2,4, Michael Pedersen2,3, Marc de Leval5, Vibeke Hjortdal1,2. 1. Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Denmark (S.M., N.T., B.K., V.H.). 2. Department of Clinical Medicine (S.M., N.T., B.K., D.B., M.P., V.H.), Aarhus University, Denmark. 3. Comparative Medicine Lab, Department of Clinical Medicine (H.L., M.P.), Aarhus University, Denmark. 4. Department of Biomedicine (D.B.), Aarhus University, Denmark. 5. The Harley Street Clinic Children's Hospital, London, United Kingdom (M.d.L.).
Abstract
BACKGROUND: The Fontan procedure has revolutionized the treatment of univentricular hearts. However, it is associated with severe complications such as protein-losing enteropathy, plastic bronchitis, and peripheral edema that may involve the lymphatic circulation. We aimed to assess lymphatic function and morphology in patients with a univentricular circulation. METHODS: The functional state of lymphatic vessels in the lower extremities of patients with a Fontan circulation (n=10) was investigated using the novel technique near-infrared fluorescence imaging and compared with an age-, sex-, and weight-matched control group of healthy volunteers (n=10). The lymphatic morphology was described using T2-weighted magnetic resonance imaging, and microvascular permeability was estimated by strain gauge plethysmography. RESULTS: The Fontan patients had 17% lower lymphatic pumping pressure (50±3.1 mm Hg) compared with controls (60±2.8 mm Hg; P=0.0341) and a 62% higher contraction frequency (0.8±0.1 min-1) compared with the healthy controls (0.5±0.1 min-1; P=0.0432). Velocity by which the lymph is moved and refill time after manual emptying of the lymphatic vessels showed no differences between the 2 groups. The thoracic duct was elongated 10% ( P=0.0409) and with an abnormal course in the Fontan patients compared with normal. No difference in microvascular permeability was found between the 2 groups. CONCLUSIONS: Patients with a Fontan circulation have an impaired lymphatic pumping capacity and morphologically changed thoracic duct. Our results indicate a challenged lymphatic vasculature in the Fontan circulation and may play a role in the pathogenesis of the complications that are seen in Fontan patients. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03379805.
BACKGROUND: The Fontan procedure has revolutionized the treatment of univentricular hearts. However, it is associated with severe complications such as protein-losing enteropathy, plastic bronchitis, and peripheral edema that may involve the lymphatic circulation. We aimed to assess lymphatic function and morphology in patients with a univentricular circulation. METHODS: The functional state of lymphatic vessels in the lower extremities of patients with a Fontan circulation (n=10) was investigated using the novel technique near-infrared fluorescence imaging and compared with an age-, sex-, and weight-matched control group of healthy volunteers (n=10). The lymphatic morphology was described using T2-weighted magnetic resonance imaging, and microvascular permeability was estimated by strain gauge plethysmography. RESULTS: The Fontan patients had 17% lower lymphatic pumping pressure (50±3.1 mm Hg) compared with controls (60±2.8 mm Hg; P=0.0341) and a 62% higher contraction frequency (0.8±0.1 min-1) compared with the healthy controls (0.5±0.1 min-1; P=0.0432). Velocity by which the lymph is moved and refill time after manual emptying of the lymphatic vessels showed no differences between the 2 groups. The thoracic duct was elongated 10% ( P=0.0409) and with an abnormal course in the Fontan patients compared with normal. No difference in microvascular permeability was found between the 2 groups. CONCLUSIONS:Patients with a Fontan circulation have an impaired lymphatic pumping capacity and morphologically changed thoracic duct. Our results indicate a challenged lymphatic vasculature in the Fontan circulation and may play a role in the pathogenesis of the complications that are seen in Fontan patients. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03379805.
Authors: Sheyanth Mohanakumar; Benjamin Kelly; Aida Luiza Ribeiro Turquetto; Mathias Alstrup; Luciana Patrick Amato; Milena Schiezari Ru Barnabe; João Bruno Dias Silveira; Fernando Amaral; Paulo Henrique Manso; Marcelo Biscegli Jatene; Vibeke Elisabeth Hjortdal Journal: Physiol Rep Date: 2021-06
Authors: Julia Moosmann; Okan Toka; Sören Lukassen; Arif B Ekici; Andreas Mackensen; Simon Völkl; Sven Dittrich Journal: Thorac Cardiovasc Surg Date: 2021-02-19 Impact factor: 1.827
Authors: Julia Moosmann; Okan Toka; Peter Linz; Anke Dahlmann; Armin M Nagel; Mario Schiffer; Michael Uder; Robert Cesnjevar; Sven Dittrich; Christoph Kopp Journal: Ther Adv Chronic Dis Date: 2021-04-16 Impact factor: 5.091
Authors: Giacomo Rossitto; Sheon Mary; Christine McAllister; Karla Bianca Neves; Laura Haddow; John Paul Rocchiccioli; Ninian Nicholas Lang; Clare Louise Murphy; Rhian Merry Touyz; Mark Colquhoun Petrie; Christian Delles Journal: J Am Coll Cardiol Date: 2020-12-15 Impact factor: 24.094
Authors: Michael Mills; Malou van Zanten; Marco Borri; Peter S Mortimer; Kristiana Gordon; Pia Ostergaard; Franklyn A Howe Journal: J Magn Reson Imaging Date: 2021-02-24 Impact factor: 4.813